Difference between revisions of "Dosulepine-tranylcypromine"

From Psychiatrienet
Jump to: navigation, search
 
(2 intermediate revisions by 2 users not shown)
Line 3: Line 3:
 
| to = tranylcypromine  
 
| to = tranylcypromine  
 
| stop =  
 
| stop =  
* '''Before day 1:''' gradually reduce dosage of dosulepine to a maximum of 75 mg/ day, when this dosage is > 75 mg/day.
+
{{Generaldecrease25p3d}}
* '''Day 1-3:''' reduce dosage of dosulepine to 50 mg/day.
+
{{14dwashout}}
* '''Day 4-7:''' reduce dosage of dosulepine to 25 mg/day.
 
* '''Day 8:''' stop administration of dosulepine.
 
 
| start =  
 
| start =  
* '''Day 8-21:''' a wash-out period of two weeks is necessary.
+
{{Starttranyl}}
* '''Day 22:''' start administration of tranylcypromine in a low dosage of 20 mg/day for one week.
 
* '''Day 29:''' after this week the dosage of tranylcypromine can be increased if necessary.
 
 
|info=
 
|info=
{{review}}
+
{{washout}}
 
}}
 
}}

Latest revision as of 13:47, 20 June 2016

dosulepin
Type antidepressant
Group TCA
links
ATC-code N06AA16
PubChem 13473
PubMed dosulepin
Kompas (Dutch) dosulepin
Wikipedia dosulepin
Tranylcypromine
Type Antidepressant
Group MAO-I
links
Medscape Tranylcypromine
PubChem 5530
PubMed Tranylcypromine
Wikipedia Tranylcypromine

Switch medication from dosulepine to tranylcypromine.

Nietinrijdenbord.png Stop dosulepine
  • Decrease with about 25% of original dose every 3 days
  • Stop and wait 14 days for washout
Eenrichtingbord.png Start tranylcypromine
  • Start tranylcypromine in a low dosage of 20 mg/day for one week.
  • After this week the dosage of tranylcypromine can be increased.
Infobord.png More information
  • A wash-out period of two weeks is necessary.
  1. 1.0 1.1 1.2 1.3 1.4 KNMP; Informatorium Medicamentorum 2015; Monografie "dosulepine" (Dutch)
  2. NVZA; Toxicology.org; Monografie 63 (dutch)
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.